Gastro-intestinal symptoms (nausea, diarrhoea, stomach pain, vomiting) are more common and sometimes stronger after each dose increase
Reconstitute in bacteriostatic water or sterile PBS, adding solvent slowly with a gentle swirling motion do not vortex
Disclosures The authors reported no conflicts of interest relevant to this article
The most frequent issues reported from the phase 3 studies are nausea (19%), fatigue (6%), skin darkening (4%), dizziness (4%), and the development of moles (4%)
The NIHR Be Part of Research service (bepartofresearch.nihr.ac.uk) is the official UK resource for finding and joining legitimate clinical trials
Frequently Asked Questions Is retatrutide the same as Mounjaro or Tirzepatide